» Articles » PMID: 32932841

On Neutrophil Extracellular Trap (NET) Removal: What We Know Thus Far and Why So Little

Overview
Journal Cells
Publisher MDPI
Date 2020 Sep 16
PMID 32932841
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Although neutrophil extracellular traps (NETs) were discovered only 16 years ago, they have already taken us from heaven to hell as we learned that apart from beneficial trapping of pathogens, they cause, or contribute to, numerous disorders. The latter is connected to their persistent presence in the blood or tissue, and we hardly know how they are removed in mild pathophysiological conditions and why their removal is impaired in multiple severe pathological conditions. Herein, we bring together all data available up till now on how NETs are cleared-from engaged cells, their phenotypes, to involved enzymes and molecules. Moreover, we hypothesize on why NET removal is challenged in multiple disorders and propose further directions for studies on NET removal as well as possible therapeutic strategies to have them cleared.

Citing Articles

Proteomic Profile Regulated by the Immunomodulatory Jusvinza Drug in Neutrophils Isolated from Rheumatoid Arthritis Patients.

Hernandez-Cedeno M, Rodriguez-Ulloa A, Ramos Y, Gonzalez L, Serrano-Diaz A, Zettl K Biomedicines. 2025; 12(12.

PMID: 39767648 PMC: 11727316. DOI: 10.3390/biomedicines12122740.


-induced NETs are highly cytotoxic on hepatic and colonic cells due to serine proteases and myeloperoxidase activities.

Jorge-Rosas F, Diaz-Godinez C, Garcia-Aguirre S, Martinez-Calvillo S, Carrero J Front Immunol. 2024; 15:1493946.

PMID: 39687618 PMC: 11646992. DOI: 10.3389/fimmu.2024.1493946.


The Application of Drugs and Nano-Therapies Targeting Immune Cells in Hypoxic Inflammation.

Luo J, Wang H, Chen J, Wei X, Feng J, Zhang Y Int J Nanomedicine. 2024; 19:3441-3459.

PMID: 38617798 PMC: 11015843. DOI: 10.2147/IJN.S456533.


Putative Role of Neutrophil Extracellular Trap Formation in Chronic Myeloproliferative Neoplasms.

Markovic D, Maslovaric I, Kovacic M, Vignjevic Petrinovic S, Ilic V Int J Mol Sci. 2023; 24(5).

PMID: 36901933 PMC: 10003516. DOI: 10.3390/ijms24054497.


DNase I and Sivelestat Ameliorate Experimental Hindlimb Ischemia-Reperfusion Injury by Eliminating Neutrophil Extracellular Traps.

Wang C, Wang Y, Jiang Q, Zeng Y, Yao Q, Liu X J Inflamm Res. 2023; 16:707-721.

PMID: 36852300 PMC: 9961174. DOI: 10.2147/JIR.S396049.


References
1.
Skendros P, Mitsios A, Chrysanthopoulou A, Mastellos D, Metallidis S, Rafailidis P . Complement and tissue factor-enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis. J Clin Invest. 2020; 130(11):6151-6157. PMC: 7598040. DOI: 10.1172/JCI141374. View

2.
Napirei M, Karsunky H, Zevnik B, Stephan H, Mannherz H, Moroy T . Features of systemic lupus erythematosus in Dnase1-deficient mice. Nat Genet. 2000; 25(2):177-81. DOI: 10.1038/76032. View

3.
Urban C, Lourido S, Zychlinsky A . How do microbes evade neutrophil killing?. Cell Microbiol. 2006; 8(11):1687-96. DOI: 10.1111/j.1462-5822.2006.00792.x. View

4.
Albrengues J, Shields M, Ng D, Park C, Ambrico A, Poindexter M . Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice. Science. 2018; 361(6409). PMC: 6777850. DOI: 10.1126/science.aao4227. View

5.
Cichon I, Ortmann W, Bednarz A, Lenartowicz M, Kolaczkowska E . Reduced Neutrophil Extracellular Trap (NET) Formation During Systemic Inflammation in Mice With Menkes Disease and Wilson Disease: Copper Requirement for NET Release. Front Immunol. 2020; 10:3021. PMC: 6974625. DOI: 10.3389/fimmu.2019.03021. View